Shared Flashcard Set

Details

ACCP-PEDS
ACCP PEDIATRICS REVIEW
57
Pharmacology
Professional
04/29/2011

Additional Pharmacology Flashcards

 


 

Cards

Term

Sepsis/Meningitis Peds

Early vs Late Onset

 

 

Definition

Early onset: within 1st 5 days of life

                  Meningitis <10% of cases

 

Late onset: after 1st week of life

                 Meningitis >60%

Term

CSF Fluid Values

Normal child

(wbc,neutrophils,glucose,protein,rbc)

Definition

 

  • wbc             0-6
  • neutrophils      0
  • glucose       40-80
  • protein        20-30
  • rbc               0-2

 

Term

 

CSF Fluid Values

Normal infant

(wbc,neutrophils,glucose,protein,rbc)

 

Definition

  • wbc             0-30
  • neutrophils    2-3
  • glucose       32-121
  • protein        19-149
  • rbc               0-2

Term

 

CSF Fluid Values

Bacterial Meningitis

(wbc,neutrophils,glucose,protein,rbc)

 

Definition

  • wbc             >1000
  • neutrophils    >50
  • glucose         <30
  • protein         >1000
  • rbc               0-10

Term

 

 

CSF Fluid Values

Viral Meningitis

(wbc,neutrophils,glucose,protein,rbc)

 

 

Definition

  • wbc            100-500
  • neutrophils     <40
  • glucose          >30
  • protein        50-100
  • rbc                0-2

Term

Sepsis/Meningitis

Common pathogens

0-1 month

Definition

  • group b strep
  • E. coli
  • Listeria
  • Viral
  • Coag-neg staph-nosocomial
  • Gm neg bacteria (pseudomonas, enterobacter)-nosocomial
  • candida

Term

 

Sepsis/Meningitis

Common pathogens

1-3 month

 

Definition

 

neonatal pathogens:
  • group b strep
  • E. coli
  • Listeria
  • Viral
  • Coag-neg staph-nosocomial
  • Gm neg bacteria (pseudomonas, enterobacter)-nosocomial
  • candida
  • and
  • H. influenzae type b
  • Neisseria menigiitidis
  • strep pneumoniae

 

Term

 

Sepsis/Meningitis

Common pathogens

3 months - 12 years

 

Definition

  • H. influenzae
  • n. meningitidis
  • s. pneumoniae

Term

 

Sepsis/Meningitis

Common pathogens

>12 years

 

Definition

  • N. meningitidis
  • S. pneumoniae

Term

Sepsis/Meningitis

Treatment Regimens

0-1 month

Definition

ampicillin + gent 

or

ampicillin +cefotaxime

Term

 

Sepsis/Meningitis

Treatment Regimens

1-3 month

 

Definition
ampicillin +cefotaxime-ceftriaxone
Term

 

Sepsis/Meningitis

Treatment Regimens

3 month-12 years

 

Definition

 

ceftriaxone +/- vanco

 

add vanco based on regional incidence of resistant s. pneumoniae

 

Term

 

Sepsis/Meningitis

Treatment Regimens

>12 years

 

Definition

ceftriaxone +/- vanco

 

add vanco based on regional incidence of resistant s. pneumoniae

Term

Chemoprophylaxis of Bacterial Meningitis

Why and who?

Definition

 

  • why:  To prevent spread of H.influ and N. meningitidis
  • who: high risk groups, household contacts, day care centers, direct contact with index patients secretions

 

Term

Chemoprophylaxis of Bacterial Meningitis

N. meningitidis

Which Drugs?

 

 

Definition

Rifampin po

ceftriaxone im

Term

Chemoprophylaxis of Bacterial Meningitis

H. Influ

Which Drugs?


Definition
Rifampin
Term

Chemoprophylaxis of Bacterial Meningitis

N. meningitidis

Drug doses per age range (3)


Definition

</= 1 month: Rifampin 5mg/kg/dose po 12h x2 days

>1 month: 10mg/kg/dose po q12h x2 daysChemoprophylaxis of Bacterial Meningitis

N. meningitidis

Which Drugs?

 adults: 600mg po q12h 2 days

 

Ceftriaxone: <12 125mg im x1

                   >12 250mg im x1

Term

 

Chemoprophylaxis of Bacterial Meningitis

H. Influ

Drug doses?


 

Definition

Rimampin:

20mg/kg/dose (max 600mg)  daily x4 days

Term

Contraindications to receiving vaccines

(6)

Definition

Anaphylactic rxn:

      a. Neomycin in inactivated polio,mmr                  varicella

       b. egg proteins in influenza,  (note                     mmr grown in chick embryo                   tissue, egg allergy not a                         contraindication) 

Acute moderate or severe febrile illness

 

Immunodeficiency with oral polio,mmr                      and varicella

 

Pregnancy with mmr, varicella

 

recent admin of immune globulin :                              mmr,varicella

 

Encephalopathy within 7 days after admin                  of a previous dose of DTap

 

Term

Misconceptions regarding contraindications to vaccination

(7)

Definition

 

  1. Mild acute illness
  2. current abx therapy
  3. rxn to DTap involving only soreness, redness or swelling at the site
  4. pregnancy of the mother of the  vaccine            recipient
  5. brestfeeding
  6. allergies to abx other than neomycin or streptomycin
  7. family hx of an adverse effect after vaccine admin

 

Term

Vaccine considerations in special populations:

preterm infants

(3)

Definition

 

  1. Immunize on the basis of chronologic age
  2. do not reduce vaccine doses
  3. delay HepB because of reduced response until patient 2kg or older than 30 days unless mother is positive

 

        

Term

Vaccine considerations in special populations:

Immunocompromised

(2)

Definition

 

  1. should not receive live vaccines                   (mmr,varicella, oral polio,rotavirus)inactivated vaccines & immune globs ok
  2. household contacts should not receive         oral polio, but mmr, influenza, varicella     and rotavirus are recommended

 

Term

Vaccine considerations in special populations:

Receiving corticosteroids

(3)

 

 

Definition

Live vaccines: may admin to pat  receiving          a. topical steroids

         b. physiologic maint doses

         c. low or mod doses (<2mg/kg/day                 of prednisone equiv.)

 

Immed after high doses  (>2mg/kg/day) have been discontinued if on for <14 days

 

1 month after high doses (>2mg/kg/day)

have been discontinued if on for >14 days

Term

Vaccine considerations in special populations:

HIV

(3)

Definition

MMR should be admin unless patient            severely immunocompromised

Varicella in asymptomatic or mildly  symptomatic patients

Inactivated vacines should be admin  routinely

 

Term

Pediatric seizures

 drugs of choice

Partial

 

 

Definition

Valproic acid

carbamazepine

phenytoin

Term

Pediatric seizures

 drugs of choice

Tonic-Clonic

Definition

Valproic acid

caramazepine

phenytoin

Term

 

Pediatric seizures

 drugs of choice

Myoclonic

 

Definition
Valproic acid
Term

 

Pediatric seizures

 drugs of choice

Absence

 

Definition

Ethosuximide

valproic acid

Term

Pediatric seizures

 drugs of choice

Lennox-Gastaut

Definition

valproic acid

topiramate

lamotrigine

Term

Pediatric seizures

 drugs of choice

Infantile spasms

Definition
adrenocorticotropic hormone (ACTH)
Term

Pediatric seizures

 Alternatives

Partial

Definition

phenobarb

gabapentin

lamotrigine

tigabine

topiramate

oxcarbazepine

zonismide

levetiracetam

Term

Pediatric seizures

 Alternatives

Tonic-Clonic

Definition

lamotrigine

opiramate

zonisamide

levetiracetam

Term

Pediatric seizures

 Alternatives

Myoclonic

 

Definition

Topriamte

zonisamide

levetiracetam

 

Term

Pediatric seizures

 Alternatives

Absence

Definition

lamotrigine

zonisamide

levetiracetam

Term

Pediatric seizures

 Alternatives

Lennox-Gastaut

Definition

Felbamate

zonisamide

Term

Pediatric seizures

 Alternatives

Infantile spasms

Definition

Vigabatrin

lamotrigine

tiagabine

topiramate

valproic acid

zonisamide

Term

Phenobarb

Adverse Effects (4)

&

Pharmacokinetic considerations (2)

Definition

Adverse Effects

 Cognitive dysfuction

 Sedation

 rash

 Decreased bone density

Pharmacokinetic

 Linear kinetics

 decreased effectiveness of oc

Term

 

Phenytoin

Adverse Effects (5)

&

Pharmacokinetic considerations (2)

 

Definition

 

Adverse Effects

 rash

 gingival hyperplasia

 hirsutism

 Decreased bone density

 Teratogenic

Pharmacokinetic

 nonlinear kinetics

 decreased effectiveness of oc

 

Term

 

Carbamazepine

Adverse Effects (4)

&

Pharmacokinetic considerations (2)

 

Definition

 

Adverse Effects

 rash

 Hyponatremia

 Decreased bone density

 Teratogenic

Pharmacokinetic

  Autoinduction

 decreased effectiveness of oc

 

Term

 

Valproic Acid

Adverse Effects (7)

&

Pharmacokinetic considerations (1)

 

Definition

 

Adverse Effects

  Weight gain

  Menstrual irregularities

  polycystic ovarian syndrome

  Hyperandrogenism

  Hepatotoxicity (most cases in child<2)

  Teratogenic

  Thrombocytopenia

 

Pharmacokinetic

 cyp inductions > in children

 

 

Term

 

Gabapentin

Adverse Effects (2)

&

Pharmacokinetic considerations (3)

 

Definition

 

Adverse Effects

  somnolence

  weight gain

 

Pharmacokinetic

 nonlinear kinetics

 increased clearance in children <6

 dose adjust in renal insuff

Other

 minimal drug interactions

 minimal cognitive effects

 may worsen Lennox-Gastaut

 

Term

 

Felbamate

Adverse Effects (4)

&

Pharmacokinetic considerations (1)

 

Definition

 

Adverse Effects

   Anorexia, nausea, weight loss

  Insomnia, somnolenc

  Aplastic anemia (adults > children)

  Hepatic failure 

Pharmacokinetic

   Clearance 50:50 renal/hepatic

 

 

Term

 

Lamaotrigine

Adverse Effects (2)

&

Pharmacokinetic considerations (1)

 

Definition

 

Adverse Effects

   Rash (children >adults)

   Steven-johnson syndrome

Pharmacokinetic

  autoinduction

Other

  Minimal Cognitive effects

 

 

Term

 

Topiramate

Adverse Effects (4)

&

Pharmacokinetic considerations (2)

 

Definition

 

Adverse Effects

 cognitive dysfunction

 weight loss

  glaucoma

  oligohidrosis (children > adults)

Pharmacokinetic

  increased clearance in children

  dose adjust in renal insuff

 

Term

 

Tiagabine

Adverse Effects (2)

&

Pharmacokinetic considerations (1)

 

Definition

 

Adverse Effects

 Dizziness

 Nonconvulsive status epilepticus

Pharmacokinetic

 clearance 50% increased in children

Other

Minimum cognitive effects

 

Term

 

Levetiracetam

Adverse Effects (2)

&

Pharmacokinetic considerations (4)

 

Definition

 

Adverse Effects

  Headache

  somnolence

Pharmacokinetic

 Linear kinetics

 Renal excreation

 clearance 40% increased in children

 no effect on cyp

 

Other

minimal drug interactions

 

Term

 

Oxcarbazepine

Adverse Effects (2)

&

Pharmacokinetic considerations (4)

 

Definition

 

Adverse Effects

 Hyponatremia >CBZ

  Rash <CBZ

Pharmacokinetic

 Linear kinetics

 Clearance 40% increased in child <6

  Induces CYP3a4

  Inhibits  CYP2C19

Other

minimum cognitive effects

 

Term

 

Zonisamide

Adverse Effects (2)

&

Pharmacokinetic considerations (2)

 

Definition

 

Adverse Effects

 Weight loss

 Rash

 Oligohidrosis

Pharmacokinetic

 Linear kinetics

 Primarily renal excretion, no effect on cyp

Other

Better tolerated by children than adults

 

Term

 

Vigabatrin

Adverse Effects (2)

&

Pharmacokinetic considerations (0)

 

Definition

 

Adverse Effects

  Vision loss

  Weight gain

Pharmacokinetic

  none

Other

  only available through restricted distribution

 

Term

ADHD

Stimulent meds

Methylphenidate

long acting (6)

Definition

 

 

Short acting-usually need 2-3 doses daily

 

Long acting:

 Methylphenidate SR/ER

   (Ritalin SR, Metadate ER)

   duration up to 8hrs, bid dosing for          afternoon symptoms usually needed  

 Methylphenidate OROS 

   (Concerta)

   duration 10-12 hours

 

 Dexmethylphenidate ER

   (Focalin XR)

   duration approx 8hrs, faster onset than concerta

 

Methylphenidate modified release

   (Metadate CD)

   duration 6-8 hrs, may be opened and        sprinkled on food

 

Methylphenidate ER

   (Ritalin ER)

    Efficacy may wane later in the day

    Capsules may be opened and sprinkled on food

 

Methylphenidate patch

    (Daytrana)

    apply 2hrs before effect needed, 

    duration up to 3 hrs after patch off

    recommended wear time 9hrs, may        to up to 16hrs

 

    *Use with caution in patients with           glaucoma, tics, psychosis and MAO         inhibitors

 

Term

ADHD

Stimulant

Amphetamine

Definition

Mixed amphetamine salts (Adderall XR)

 Duration 10-12 hrs

 may be opened and sprinkled on food

 

Lisdexamfetamine dimesylate (Vyvanse)

 Duration 10 hrs

Term

ADHD

SCD and  Stimulants

Definition

No evidence of causative relationship between stimulants and SCD.

 

AAP recommends targeted cardiac hx and careful exam before starting.

 

Routine ECG not recommended unless hx and physical suggest caridac disease

Term

ADHD

Non-Stimulant Meds types

 

Definition

atomoxetine

antidepressants - not FDA approved

  noradrenergic

  tricyclics

alpha-adreneric receptor agonists

  clonidine - not FDA approved

  Guanfacine - FDA approved

Supporting users have an ad free experience!